PUMA BIOTECHNOLOGY, INC. Employee-related Liabilities, Current
PUMA BIOTECHNOLOGY, INC. (PBYI) had Employee-related Liabilities, Current of $5.41 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:EmployeeRelatedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Employee-related Liabilities, Current $5.41M.
- 2026-03-31: Employee-related Liabilities, Current $5.36M.
- 2025-12-31: Employee-related Liabilities, Current $5.80M.
- 2025-09-30: Employee-related Liabilities, Current $5.42M.
| Period end | Employee-related Liabilities, Current | Employee-related Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $5.41M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $5.36M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $5.80M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $5.42M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $5.78M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $4.70M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $4.37M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $4.36M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $4.66M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $4.48M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $4.38M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $4.23M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $4.61M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $4.39M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $4.30M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $4.18M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $4.15M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $4.21M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $3.88M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $4.37M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $4.70M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $5.13M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $4.82M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $4.69M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $5.34M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $4.20M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $4.14M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $3.57M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $4.09M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $4.11M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $4.43M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $4.44M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $4.26M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $4.36M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $2.80M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $8.49M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $5.87M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $3.98M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $1.99M 10-K · filed 2018-03-09 | $3.06M 10-K · filed 2017-03-01 |
| 2016-09-30 | $5.26M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $4.06M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $3.34M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $1.97M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $3.73M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $3.13M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $3.04M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $2.45M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $2.98M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $2.42M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $1.72M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $1.07M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $1.87M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $1.53M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $1.06M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $787.00K 10-K · filed 2014-03-03 | |
| 2012-09-30 | $1.25M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $975.61K 10-Q · filed 2012-08-14 | |
| 2011-12-31 | $309.00K 10-K · filed 2013-04-01 | $308.94K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |